Search Results
Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results
TGR-1202, ublituximab and ibrutinib combination for advanced CLL and NHL
Long-Term Results of Ibrutinib/Umbralisib Show Efficacy in CLL and MCL
Final results of the AIM study of ibrutinib and venetoclax in mantle cell lymphoma
Dr. Tam on the Combination of Ibrutinib Plus Venetoclax in Mantle Cell Lymphoma
The success of ibrutinib in treating mantle cell lymphoma (MCL)
Interim Data of Cirmtuzumab and Ibrutinib Show Efficacy in MCL and CLL
TGR-1202 + ibrutinib in patients with R/R CLL
Dr. Rule on the Combination of Venetoclax and Ibrutinib in MCL
Results for the Combination of Ublituximab and Ibrutinib in CLL
Tolerability and Activity of Chemo-Free Triplet Combination of TGR-1202 (Ublituximab)...
Adding umbralisib to ibrutinib produced responses in MCL, CLL
